No data are available on enteropeptidase expression in these neoplasms in a clinical setting, but our results warrant further work to delineate its potential in tumor progression and, especially, to better define the role of antithrombin, enteropeptidase and heparin in their angiogenic behavior. The gene discussed is TMPRSS15; the disease is neoplasm.